Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amber Willbanks"'
Autor:
Sarah Heerboth, Genevieve Housman, Meghan Leary, Mckenna Longacre, Shannon Byler, Karolina Lapinska, Amber Willbanks, Sibaji Sarkar
Publikováno v:
Clinical and Translational Medicine, Vol 4, Iss 1, Pp n/a-n/a (2015)
AbstractEMT and MET comprise the processes by which cells transit between epithelial and mesenchymal states, and they play integral roles in both normal development and cancer metastasis. This article reviews these processes and the molecular pathway
Externí odkaz:
https://doaj.org/article/33b9069abe1243d6a712a262304a6233
Autor:
Ming Yu, Helen R. Moinova, Amber Willbanks, Victoria K. Cannon, Ting Wang, Kelly Carter, Andrew Kaz, Deepti Reddi, John Inadomi, Georg Luebeck, Prasad G. Iyer, Marcia I. Canto, Jean S. Wang, Nicholas J. Shaheen, Prashanti N. Thota, Joseph E. Willis, Thomas LaFramboise, Amitabh Chak, Sanford D. Markowitz, William M. Grady
Publikováno v:
Clin Cancer Res
Purpose: Current endoscopy-based screening and surveillance programs have not been proven effective at decreasing esophageal adenocarcinoma (EAC) mortality, creating an unmet need for effective molecular tests for early detection of this highly letha
Autor:
William M. Grady, Sanford D. Markowitz, Amitabh Chak, Thomas LaFramboise, Joseph E. Willis, Prashanti N. Thota, Nicholas J. Shaheen, Jean S. Wang, Marcia I. Canto, Prasad G. Iyer, Georg Luebeck, John Inadomi, Deepti Reddi, Andrew Kaz, Kelly Carter, Ting Wang, Victoria K. Cannon, Amber Willbanks, Helen R. Moinova, Ming Yu
Purpose:Current endoscopy-based screening and surveillance programs have not been proven effective at decreasing esophageal adenocarcinoma (EAC) mortality, creating an unmet need for effective molecular tests for early detection of this highly lethal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cca7d72d22cb5142304ceb7e57dcd31
https://doi.org/10.1158/1078-0432.c.6532413
https://doi.org/10.1158/1078-0432.c.6532413
Autor:
William M. Grady, Sanford D. Markowitz, Amitabh Chak, Thomas LaFramboise, Joseph E. Willis, Prashanti N. Thota, Nicholas J. Shaheen, Jean S. Wang, Marcia I. Canto, Prasad G. Iyer, Georg Luebeck, John Inadomi, Deepti Reddi, Andrew Kaz, Kelly Carter, Ting Wang, Victoria K. Cannon, Amber Willbanks, Helen R. Moinova, Ming Yu
Supplementary Data from Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731a53f048e0540b003f013e7c7a114a
https://doi.org/10.1158/1078-0432.22486905
https://doi.org/10.1158/1078-0432.22486905
Autor:
William M. Grady, Sanford D. Markowitz, Amitabh Chak, Thomas LaFramboise, Joseph E. Willis, Prashanti N. Thota, Nicholas J. Shaheen, Jean S. Wang, Marcia I. Canto, Prasad G. Iyer, Georg Luebeck, John Inadomi, Deepti Reddi, Andrew Kaz, Kelly Carter, Ting Wang, Victoria K. Cannon, Amber Willbanks, Helen R. Moinova, Ming Yu
Supplementary Figure from Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::047ed3f87ca8bedb36f7428af682f52d
https://doi.org/10.1158/1078-0432.22486902
https://doi.org/10.1158/1078-0432.22486902
Autor:
William M. Grady, Jean de Dieu Tapsoba, Ming Yu, Ching-Yun Wang, Catherine Duggan, Anne McTiernan, Amber Willbanks
Publikováno v:
Epigenetics. 17:1070-1079
Physical activity reduces risk of colon cancer persons by 20-30%. Aberrant methylation patterns are common epigenetic alterations in colorectal adenomas and cancers, and play a role in cancer initiation and progression. Alterations have been identifi
Publikováno v:
Genes, Vol 12, Iss 627, p 627 (2021)
Genes
Genes
Chromatin structure plays an essential role in eukaryotic gene expression and cell identity. Traditionally, DNA and histone modifications have been the focus of chromatin regulation; however, recent molecular and imaging studies have revealed an inti
Publikováno v:
Current cancer drug targets. 21(4)
The advent of new genome-wide sequencing technologies has uncovered abnormal RNA modifications and RNA editing in a variety of human cancers. The discovery of reversible RNA N6-methyladenosine (RNA: m6A) by fat mass and obesity-associated protein (FT
Publikováno v:
Blood. 138:2242-2242
Background: Drug selectivity and resistance is a major obstacle to successful cancer therapy, including traditional chemotherapies (Vasan, N. et al. Nature 2019), immunotherapy (Hu-Lieskovan, S. et al. Future Oncol, 2021), and epigenetic therapy (Sal
Publikováno v:
Blood. 136:13-14
Background: Combinations of venetoclax/ABT-199, a small molecule that selectively inhibits anti-apoptotic protein BCL2, with hypomethylating agents (HMAs), such as 5-azacytidine (5-AZA, azacidtine) and decitabine have demonstrated remarkable synergis